Disease correction the iPSC way: Advances in iPSC-based therapy

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 5, 2011, Pages 746-749

  Sancho Martinez, I ^a   Li, M ^a   Izpisua Belmonte, J C ^a,b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b Center for Regenerative Medicine   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL RENEWAL; CELL TYPE; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE SYSTEM; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE;

ANIMALS; GENE TARGETING; GENE THERAPY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

EID: 79955466666     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.341     Document Type: Article

References (30)

1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
2. Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106 (2008).
3. Scheper, W. & Copray, S. The molecular mechanism of induced pluripotency: a two-stage switch. Stem Cell Rev. 5, 204-223 (2009).
4. Huangfu, D. et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26, 795-797 (2008). (Pubitemid 351961456)
5. Giorgetti, A. et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353-357 (2009).
6. Aasen, T. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276-1284 (2008).
7. Huangfu, D. et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26, 1269-1275 (2008).
8. Maherali, N. & Hochedlinger, K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3, 595-605 (2008).
9. Li, W. et al. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4, 16-19 (2009).
10. Ichida, J.K. et al. a small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 5, 491-503 (2009).
11. Feng, B., Ng, J.H., Heng, J.C. & Ng, H.H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4, 301-312 (2009).
12. Jia, F. et al. a nonviral minicircle vector for deriving human iPS cells. Nat. Methods 7, 197-199 (2010).
13. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNa. Cell Stem Cell 7, 618-630 (2010).
14. Xu, D. et al. Phenotypic correction of murine hemophilia a using an iPS cellbased therapy. Proc. Natl. Acad. Sci. USA 106, 808-813 (2009).
15. Hanna, J. et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923 (2007).
16. Raya, A. et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460, 53-59 (2009).
17. Yamanaka, S. & Blau, H.M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 465, 704-712 (2010).
18. Zwaka, T.P. & Thomson, J.A. Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 21, 319-321 (2003). (Pubitemid 36314818)
19. Ruby, K.M. & Zheng, B. Gene targeting in a HUES line of human embryonic stem cells via electroporation. Stem Cells 27, 1496-1506 (2009).
20. Pyle, A.D., Lock, L.F. & Donovan, P.J. Neurotrophins mediate human embryonic stem cell survival. Nat. Biotechnol. 24, 344-350 (2006). (Pubitemid 43372159)
21. Watanabe, K. et al. a ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681-686 (2007). (Pubitemid 46897207)
22. Song, H., Chung, S.K. & Xu, Y. Modeling disease in human ESCs using an efficient BaC-based homologous recombination system. Cell Stem Cell 6, 80-89 (2010).
23. Zou, J. et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5, 97-110 (2009).
24. Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851-857 (2009).
25. Buecker, C. et al. a murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. Cell Stem Cell 6, 535-546 (2010).
26. Suzuki, K. et al. Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors. Proc. Natl. Acad. Sci. USA 105, 13781-13786 (2008).
27. Khan, I.F. et al. Engineering of human pluripotent stem cells by aaV-mediated gene targeting. Mol. Ther. 18, 1192-1199 (2010).
28. Mitsui, K. et al. Gene targeting in human pluripotent stem cells with adenoassociated virus vectors. Biochem. Biophys. Res. Commun. 388, 711-717 (2009).
29. Lombardo, A. et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25, 1298-1306 (2007). (Pubitemid 350076515)
30. Galetto, R., Duchateau, P. & Pâques, F. Targeted approaches for gene therapy and the emergence of engineered meganucleases. Expert Opin. Biol. Ther. 9, 1289-1303 (2009).